Hemidiaphragm paresis and granulomatous pneumonitis associated with adalimumab: A case report
Author/Authors :
Abdallah، نويسنده , , Tarek and Abdallah، نويسنده , , Mokhtar and Saifan، نويسنده , , Chadi and El Sayegh، نويسنده , , Dany and Chalhoub، نويسنده , , Michel and Sasso، نويسنده , , Louis، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 2014
Pages :
3
From page :
84
To page :
86
Abstract :
Adalimumab is a fully human monoclonal anti-TNF-alpha antibody. Reported adverse effects have raised a number of safety concerns associated with their prolonged use. A case of granulomatous pneumonitis and hemidiaphragm paresis associated with adalimumab
